×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cocrystal Pharma Advances Promising Influenza A Drug - TipRanks.com
Tipranks
Cocrystal Pharma Inc (COCP) has issued an update. Cocrystal Pharma, Inc. has announced progress in the clinical development of their...
3 days ago
Cocrystal Pharma (NASDAQ:COCP) and Milestone Pharmaceuticals (NASDAQ:MIST) Critical Survey
Defense World
Read Cocrystal Pharma (NASDAQ:COCP) and Milestone Pharmaceuticals (NASDAQ:MIST) Critical Survey at Defense World.
4 days ago
Cocrystal Pharma (COCP) Jumps: Stock Rises 7.3%
Yahoo
Cocrystal Pharma (COCP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
4 days ago
Seattle company founded by Nobel Prize winner plans human tests for experimental COVID-19 drug
GeekWire
Cocrystal Pharma co-founder Roger Kornberg won the Nobel Prize in Chemistry for revealing the high-resolution structure of a protein complex...
8 months ago
Cocrystal announces completion of enrollment in Phase 2a study of CC-42344 - TipRanks.com
Tipranks
Cocrystal Pharma announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind,...
3 days ago
Cocrystal Pharma (COCP) Completes Research Obligations With Merck
Yahoo
Cocrystal Pharma, Inc. COCP announced that it has completed all research obligations under the Merck MRK exclusive worldwide license and collaboration...
6 days ago
Cocrystal receives approval for Phase I trial of Covid-19 therapy
Clinical Trials Arena
Cocrystal Pharma has received approval from the Australian Human Research Ethics Committee (HREC) to initiate a Phase I trial of CDI-988 for...
11 months ago
ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656
Business Wire
ClinConnect, a first-of-its-kind platform redefining how patients and clinical trials find each other, today announced a partnership with...
6 months ago
Cocrystal Pharma, Inc. (NASDAQ:COCP) Forecasted to Post Q3 2024 Earnings of ($0.59) Per Share
Defense World
Read Cocrystal Pharma, Inc. (NASDAQ:COCP) Forecasted to Post Q3 2024 Earnings of ($0.59) Per Share at Defense World.
1 week ago